{'fraction_non_alphanumeric': 0.03518518518518519, 'fraction_numerical': 0.01574074074074074, 'mean_word_length': 6.01948051948052, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The 21st annual meeting of the Canadian College of Neuropsychopharmacology. Montreal, Canada, June 14-17, 1998.

The 21st annual meeting of the Canadian College of Neuropsychopharmacology (CCNP) was marked by participation of an unprecedented number of registrants > 200, comprising psychiatrists, pharmacologists, and neuroscientists from Canada and the U.S.A. The presentations consisted of four plenary lectures, three award lectures, eight symposia, and 97 posters. The major themes in the meeting included schizophrenia, Alzheimer’s, substance dependence, affective disorder, pain, personality disorder, neural growth and degeneration, and pharmacogenetics. A special symposium entitled “Molecular Approaches to Neural Dysfunction” organized with the Canadian Association for Neuroscience highlighted the recent advances in the molecular basis of neurodegenerative diseases and mechanisms of neural growth. The scientific sessions were preceded by a public lecture, organized by the CCNP and given by J. Rapoport (NIMH, Bethesda), on attention deficit hyperactivity disorder.